http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2541918-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33a26b4df3a9ca4fec659d600a1d73d9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222 |
| filingDate | 2008-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0658672d386dedcc6f4b90e5dc21f37f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f9b5d113ad2564ad3542a15432163f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08a7978e9be3652a60b95e426632e440 |
| publicationDate | 2015-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2541918-T3 |
| titleOfInvention | Pharmaceutical composition that combines an antiarthritic agent and an interleukin-1 inhibitor agent, which can be used to control and treat osteoarthritis and related diseases |
| abstract | The present invention relates to a pharmaceutical composition composed of the synergistic combination of an antiarthritic agent, known as: Chondroitin Sulfate and an Interleukin-1 inhibitor, known as: Diacerein, in addition to pharmaceutically acceptable excipients, which are found formulated in a single dose unit to be administered orally, useful for the control and treatment of Osteoarthritis and related diseases, which provides a greater therapeutic effect, a greater rapidity of pharmacological action in less time, with pain reduction, inflammation and modification of the course of structural disease of articular cartilage, as well as lower risks of presenting severe complications and / or side effects. |
| priorityDate | 2007-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.